To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
- Last Action
- 2/21/2025
Actions
- 2025-02-21Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-21Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-21Introduced in House
- 2025-02-21Introduced in House
CRS Summary
As of 2025-02-21 (00)
This bill lengthens the amount of time for which drug products must have market approval in order for the products to qualify for negotiation under the Medicare Drug Price Negotiation Program.
The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.
The bill modifies these provisions so as to require drug products to also have had at least 11 years of market approval in order to qualify for negotiation.
The bill's changes apply retroactively.
Cosponsors (20)
- Donald Davis (D-NC)
- Richard Hudson (R-NC)
- Dan Crenshaw (R-TX)
- Carol Miller (R-WV)
- Claudia Tenney (R-NY)
- Thomas Kean (R-NJ)
- Mariannette Miller-Meeks (R-IA)
- Nicole Malliotakis (R-NY)
- Tim Moore (R-NC)
- Neal Dunn (R-FL)
- Beth Van Duyne (R-TX)
- Vern Buchanan (R-FL)
- Rudy Yakym (R-IN)
- Nathaniel Moran (R-TX)
- August Pfluger (R-TX)
- Addison McDowell (R-NC)
- Andy Harris (R-MD)
- Brian Fitzpatrick (R-PA)
- James Comer (R-KY)
- Bryan Steil (R-WI)
Subjects
- Health care costs and insurance
- Medicare
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.